CausalSentinel

Protein Dossier — CD33 (Myeloid cell surface antigen CD33)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Alzheimer’s disease 0.1 0.0185 6.66e-08 Wald ratio 1 cis 0.998
Non-cancer illness code self-reported: asthma 0.0271 0.00739 2.50e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: I84 Haemorrhoids 0.0479 0.0166 0.00391 Wald ratio 1 cis NA
Diagnoses - main ICD10: I30 Acute pericarditis 0.31 0.115 0.00717 Wald ratio 1 cis NA
Cancer code self-reported: basal cell carcinoma 0.0709 0.0264 0.00718 Wald ratio 1 cis NA
Platelet count 1.19 0.467 0.0109 Wald ratio 1 cis NA
HbA1C 0.00996 0.00403 0.0134 Wald ratio 1 cis NA
Body mass index (BMI) 0.00669 0.00271 0.0136 Wald ratio 1 cis NA
Diastolic blood pressure automated reading 0.00635 0.00278 0.0221 Wald ratio 1 cis NA
Weight 0.00503 0.00239 0.0355 Wald ratio 1 cis NA
Eye problems or disorders: Injury or trauma resulting in loss of vision 0.0673 0.0331 0.0424 Wald ratio 1 cis NA
Pancreatic cancer -0.11 0.0548 0.0438 Wald ratio 1 cis NA
…and 101 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3166_92_1 Siglec-3 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

201 association rows across 105 traits (189 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating CD33 levels 2e-9500 rs2455069 1 GCST90860706 no MR -> candidate analysis
Myeloid cell surface antigen CD33 levels 3e-1638 rs12459419 11 GCST90248431 no MR -> candidate analysis
Cerebrospinal fluid protein CD33 levels 2e-524 rs2455069 1 GCST90944163 no MR -> candidate analysis
Myeloid cell surface antigen CD33 levels (CD33.3166.92.1) 9e-445 rs12459419 2 GCST90241989 no MR -> candidate analysis
Blood protein levels 6e-372 rs1354106 1 GCST006585 no MR -> candidate analysis
CD33 protein levels 4e-214 rs117533019 12 GCST90468625 no MR -> candidate analysis
CD33 on CD33dim HLA DR+ CD11b+ 2e-191 rs3865444 2 GCST90001948 no MR -> candidate analysis
CD33 on CD14+ monocyte 1e-190 rs3865444 3 GCST90001946 no MR -> candidate analysis
CD33 on CD33+ HLA DR+ CD14- 9e-189 rs3865444 3 GCST90001957 no MR -> candidate analysis
CD33 on CD33+ HLA DR+ 3e-187 rs3865444 3 GCST90001956 no MR -> candidate analysis
CD33 on CD33+ HLA DR+ CD14dim 8e-184 rs3865444 2 GCST90001947 no MR -> candidate analysis
CD33 on CD33dim HLA DR+ CD11b- 2e-183 rs3865444 2 GCST90001949 no MR -> candidate analysis
…and 93 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 633 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Alzheimer disease 0.724 common-variant locus no MR -> candidate analysis
late-onset Alzheimers disease 0.576 common-variant locus no MR -> candidate analysis
smoking initiation 0.549 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 6 known modulators (Myeloid cell surface antigen CD33)
gnomAD constraint pLI=1.3e-07, LOEUF=1.11 — LoF-tolerant
GWAS Catalog 142 unique SNPs / 330 rows
ClinVar 89 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance